Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.38 USD | +4.04% | +7.88% | -12.57% |
May. 30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
May. 16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
180M | - | - | - | - | - | |
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |